Journals / Anadolu Kardiyoloji Dergisi / 2012 / Cilt: 12 - Sayı: 2

Inkomplet Kawasaki hastalığı'nda periferik eozinofili gözlem çalışması

An observational study on peripheral blood eosinophilia in incomplete Kawasaki disease

Pages
160–164
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Since the diagnosis of iKD is difficult, unexplained eosinophilia may be helpful in the presence of suggestive clinical findings of KD.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To investigate the peripheral blood eosinophilia (PBE) in the acute stage of incomplete Kawasaki disease (iKD).
📊
Key Findings & Data:Methods: Twenty-four patients with iKD (median age; 31.5 months, range; 7-88 months) and 25 with complete Kawasaki disease (cKD) (median age; 37 months, range; 9-140 months) were evaluated between 2004 and 2010 from İzmir Dr.
💡
Conclusion & Impact:Since the diagnosis of iKD is difficult, unexplained eosinophilia may be helpful in the presence of suggestive clinical findings of KD.
🔬Design:Research Article
📍Scope:2004 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: To investigate the peripheral blood eosinophilia (PBE) in the acute stage of incomplete Kawasaki disease (iKD). Methods: Twenty-four patients with iKD (median age; 31.5 months, range; 7-88 months) and 25 with complete Kawasaki disease (cKD) (median age; 37 months, range; 9-140 months) were evaluated between 2004 and 2010 from İzmir Dr. Behçet Uz Children’s Hospital records retrospec- tively. We determined the eosinophil counts and rates from the complete blood count in two study groups before the IVIG treatment and 30 febrile age-matched controls and 30 control cases with congenital heart disease (control Group 1 and 2 respectively). Kruskal-Wallis test was performed in detecting the differences of eosinophil rates and counts between four subgroups. Results: In iKD group, the mean value of eosinophil rates and median value of eosinophil counts were 4.39±2.5% and 377 cells/mm3, respec- tively, which did not significantly different with cKD group (mean eosinophil rates; 5.47±4.8% and median eosinophil counts 525 cells/mm3) (p>0.05). The median values of eosinophil cell counts and mean value of eosinophil rates were 220 cell/mm3 and 2.83±2.65% in the control group 1 and 165 cell/mm3 and 1.63±1.43% in the control Group 2 respectively, which were statistically significant lower compared to both study groups (p< 0.001). Conclusion: The rate of PBE was found significantly higher in iKD patients compared to the controls. Since the diagnosis of iKD is difficult, unexplained eosinophilia may be helpful in the presence of suggestive clinical findings of KD.

Özet

Amaç: İnkomplet Kawasaki hastalığı’nın (iKD) akut evresinde periferik kan eozinofilisinin (PKE) araştırılması amaçlandı. Yöntemler: Yirmi dört iKD (ortanca yaş; 31.5 ay, yaş aralığı; 7-88 ay) ve 25 komplet Kawasaki Hastalığı (kKD) tanılı hasta (ortanca yaş; 37 ay, yaş aralığı; 9-140 ay), 2004-2010 yılları arasında İzmir Dr. Behçet Uz Çocuk Hastanesi kayıtlarından retrospektif olarak değerlendirildi. Çalışmaya yaş olarak çalışma grubu ile uyumlu, ateşi olan 30 vaka (kontrol 1) ile konjenital kalp hastalıklı 30 vaka (kontrol 2) kontrol grubu olarak dahil edildi ve kontrol, çalışma grupları eozinofil yüzdeleri ve eozinofil hücre sayıları açsısından IVIG tedavisi öncesinde karşılaştırıldı. Kontrol ve çalışma grupları arasındaki eozinofil farklılıklarını saptamada Kruskal-Wallis testi kullanıldı. Bulgular: İnkomplet Kawasaki hastalarında PKE görülme yüzdesi ve ortalama değeri sırasıyla %66.6 ve 377 hücre/mm3 iken cKD grubunda ise sırasıyla; %60 ve 525 hücre/mm3 idi ve iki grup arasında her iki değer açısından da anlamlı fark saptanmadı (p>0.05). Eozinofil hücre sayısının ortanca değeri ile eozinofili yüzdesinin ortalama değeri sırasıyla 1. kontrol grubunda 220 hücre/mm3 ve %2.83±2.65 iken 2.kontrol grubunda ise 165 hücre/mm3 ve %1.63±1.43 idi, ve bu değerler çalışma grubunda saptananlara göre istatistiksel anlamlı olarak düşüktü (p

🔖

Cite This Article

MEŞE, T., ÖNER, T., GÜVEN, B., TAVLI, V., VİTRİNEL, A., DEMİRPENÇE, S., DEVRİM, İ., YILMAZER, M. M., VUPA, Ö. Ç. (2022). Inkomplet Kawasaki hastalığı'nda periferik eozinofili gözlem çalışması. Anadolu Kardiyoloji Dergisi, Cilt: 12 - Sayı: 2, 160–164. https://ajindex.com/articles/436346

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2004;110:2747-71. [CrossRef] 2. Benseler SM, McCrindle BW, Silverman ED, Tyrrell PN, Wong J, Yeung RS. Infections and Kawasaki disease: implications for coronary artery outcome. Pediatrics 2005; 116: 760-6. [CrossRef] 3. Brown TJ, Crawford SE, Cornwall ML, Garcia F, Shulman ST, Rowley AH. CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease. J Infect Dis 2001;184:940-3. [CrossRef] 4. Rowley AH, Eckerley CA, Jäck HM, Shulman ST, Baker SC. IgA plasma cells in vascular tissue of patients with Kawasaki syndrome. J Immunol 1997;159:5946-55. 5. Newburger J. Kawasaki Disease. In: Anderson RH, Baker EJ, Redington A, Rigby ML, Penny D, Wernovsky G, editors. Paediatric Cardiology, 3rd ed. Philadelphia: Churchill Livingstone; 2009. p.1067-78. 6. Terai M, Yasukawa K, Honda T, Jibiki T, Hirano K, Sato J, et al. Peripheral blood eosinophilia and eosinophil accumulation in coronary microvessels in acute Kawasaki disease. Pediatr Infect Dis J 2002; 21: 777-81. [CrossRef] 7. Fujiwara H, Hamashima Y. Pathology of the heart in Kawasaki disease. Pediatrics 1978; 61:100-7. 8. Rothenberg ME. Eosinophilia. N Eng J Med 1998; 338: 1592-600. [CrossRef] 9. Yılmazer MM, Meşe T, Demirpençe S, Tavlı V, Devrim I, Güven B, et al. Incomplete (atypical) Kawasaki disease in a young infant with remarkable paucity of signs. Rheumatol Int 2010; 30: 991-2. [CrossRef] 10. Kuo HC, Yang KD, Liang CD, Bong CN, Yu HR, Wang L, et al. The relationship of eosinophilia to intravenous immunoglobulin treatment failure in Kawasaki disease. Pediatr Allergy Immunol 2007;18:354-9. [CrossRef] 11. Kuo HC, Wang CL, Liang CD, Yu HR, Huang CF, Wang L, et al. Association of lower eosinophil-related T helper 2 (Th2) cytokines with coronary artery lesions in Kawasaki disease. Pediatr Allergy Immunol 2009; 20: 266-72. [CrossRef] 12. Takahashi M, Newburger JW, Kawasaki Syndrome (Mucocutaneous Lymph Node Syndrome). In: Allen HD, Driscoll DJ, Shaddy RE, Feltes TF, editors. Moss and Adams' Heart Disease in Infants, Children, and Adolescents: Including the Fetus and Young Adult. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2008. p.124